A 3-year-old boy with watery diarrhea for the past three days as well as vomiting and fever that started the day prior is brought to the emergency department by his mother. No recent traveling or antibiotic usage is reported. He has otherwise been in good health. On physical exam, the patient appears well-developed, nourished, alert, and oriented. The vitals are stable, and the abdomen is non-tender and non-distended. At shift change, the patient’s condition seems to be improving. He can tolerate apple juice and no longer has fever. The patient is signed out to the incoming physician with pending diagnostic studies.
Explore This IssueACEP Now: Vol 36 – No 07 – July 2017
However, the patient starts to develop tarry black stools shortly after shift change, and on reassessment, the patient’s blood pressure is 80/45. He appears to be pale with a rapidly deteriorating clinical status. The initial diagnostic studies are significant for hematuria, metabolic acidosis with elevated creatinine, and C-reactive protein. Abdominal X-ray shows increased bowel gas (see Figure 1), and abdominal ultrasound does not suggest any radiographic evidence of intussusception. Two hours after shift change, the patient becomes more hypotensive, and his abdomen becomes more rigid. Emergent critical care transport is initiated while the patient is placed on vasopressors to maintain a systolic blood pressure above 90. The patient is transported to a tertiary pediatric facility, where his stool culture was positive for Escherichia coli 0157, the most common cause of hemolytic uremic syndrome (HUS) in the United States. Fortunately, the patient is diagnosed, treated for HUS, and makes a full recovery.
This case highlights the importance of recognizing the symptoms of HUS. HUS is a serious complication resulting from E. coli infection, most often with Shiga toxin–producing E. coli (STEC). The toxins produced by STEC activate the endothelium, create a prothrombotic state, and lead to inflammation. E. coli 0157 is the most common strain of STEC in the United States and accounts for more than 90 percent of HUS cases in children under 5 years of age. About 5 percent to 15 percent of people infected with STEC develop HUS. The incidence is about 2–3 per 100,000 children under 5 years of age in the United States.1,2 HUS can have severe complications, and early recognition and treatment are paramount to preventing morbidity and mortality.